Keywords
MedicineAtrial fibrillationWarfarinAspirinStroke (engine)Internal medicinePopulationEmbolismCardiologyRelative riskClinical endpointRandomized controlled trialAbsolute risk reductionAnesthesiaConfidence interval
Affiliated Institutions
Related Publications
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
In patients with atrial fibrillation, rivaroxaban was noninferior to warfarin for the prevention of stroke or systemic embolism. There was no significant between-group differenc...
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
Background— Dabigatran 150 and 110 mg twice a day and warfarin are effective for stroke prevention in atrial fibrillation. The purpose of this study was to compare their risks o...
Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation
Background— Previous studies provide conflicting results about whether women are at higher risk than men for thromboembolism in the setting of atrial fibrillation (AF). We exami...
Stroke risk in atrial fibrillation patients on warfarin
Summary Atrial fibrillation (AF) patients are widely heterogeneous in terms of ischaemic stroke risk, and several risk stratification schemes have been developed. We performed a...
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
Adjusted-dose warfarin and antiplatelet agents reduce stroke by approximately 60% and by approximately 20%, respectively, in patients who have atrial fibrillation. Warfarin is s...
Publication Info
- Year
- 2007
- Type
- article
- Volume
- 370
- Issue
- 9586
- Pages
- 493-503
- Citations
- 1555
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1555
OpenAlex
Cite This
Jonathan Mant,
Richard Hobbs,
Kate Fletcher
et al.
(2007).
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
The Lancet
, 370
(9586)
, 493-503.
https://doi.org/10.1016/s0140-6736(07)61233-1
Identifiers
- DOI
- 10.1016/s0140-6736(07)61233-1